| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.09 | 0.005 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.008 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |